Sirolimus reduced skin cancer incidence in renal transplant recipients Endocrine Today PHILADELPHIA — The use of sirolimus led to a statistically significant reduction in the number of skin cancers among kidney transplant patients, according to data presented here. The research was conducted in the Netherlands and the United Kingdom. ... |
